Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirk N Garratt

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Journal of the American Heart Association|May 30, 2020
ST-Segment-Elevation Myocardial Infarction Care in America: Celebration and AnxietyKirk N Garratt
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 11, 2018
Restructuring SCAI Committees for SuccessKirk N Garratt
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 15, 2017
Fabulous at 40Kirk N Garratt
Circulation|November 14, 2014
Challenges and importance of finding hidden confounders when conducting comparative effectiveness studies using registry data: the impact of surgical turn-down on percutaneous coronary intervention mortalityKirk N Garratt
Progress in Cardiovascular Diseases|September 8, 2015
Duration of Dual Anti-Platelet Therapy Post-Percutaneous Intervention: Is There A Correct Amount of Time?Kirk N Garratt
JACC. Cardiovascular Interventions|January 25, 2015
Should interventionalist work hours be restricted after a night on call?Kirk N Garratt
Journal of Cardiovascular Pharmacology and Therapeutics|June 21, 2017
Remote Ischemic Conditioning: The Commercial Market: LifeCuff PerspectiveKirk N Garratt, Boris Leschinsky
Interventional Cardiology Clinics|June 6, 2017
Percutaneous Assist Devices for Infarct Size ReductionHammad Saudye, Kirk N Garratt
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 13, 2017
The "appropriateness" of AUC for peripheral arterial disease: The story continues…Kenneth Rosenfield, Kirk N Garratt
The New England Journal of Medicine|October 6, 2009
Therapies for type 2 diabetes and coronary artery diseaseKirk N Garratt, Steven R Bailey
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Journal of the American Heart Association|May 30, 2020
ST-Segment-Elevation Myocardial Infarction Care in America: Celebration and AnxietyKirk N Garratt
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|April 11, 2018
Restructuring SCAI Committees for SuccessKirk N Garratt
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 15, 2017
Fabulous at 40Kirk N Garratt
Circulation|November 14, 2014
Challenges and importance of finding hidden confounders when conducting comparative effectiveness studies using registry data: the impact of surgical turn-down on percutaneous coronary intervention mortalityKirk N Garratt
Progress in Cardiovascular Diseases|September 8, 2015
Duration of Dual Anti-Platelet Therapy Post-Percutaneous Intervention: Is There A Correct Amount of Time?Kirk N Garratt
JACC. Cardiovascular Interventions|January 25, 2015
Should interventionalist work hours be restricted after a night on call?Kirk N Garratt
Journal of Cardiovascular Pharmacology and Therapeutics|June 21, 2017
Remote Ischemic Conditioning: The Commercial Market: LifeCuff PerspectiveKirk N Garratt, Boris Leschinsky
Interventional Cardiology Clinics|June 6, 2017
Percutaneous Assist Devices for Infarct Size ReductionHammad Saudye, Kirk N Garratt
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 13, 2017
The "appropriateness" of AUC for peripheral arterial disease: The story continues…Kenneth Rosenfield, Kirk N Garratt
The New England Journal of Medicine|October 6, 2009
Therapies for type 2 diabetes and coronary artery diseaseKirk N Garratt, Steven R Bailey
Pageof 10